AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $190,412 | -77.3% | 24,506 | -87.4% | 0.00% | -100.0% |
Q4 2022 | $839,294 | -36.8% | 194,281 | +81.0% | 0.00% | -33.3% |
Q1 2022 | $1,329,000 | -71.4% | 107,318 | -47.1% | 0.00% | -66.7% |
Q4 2021 | $4,642,000 | +1432.0% | 202,992 | +983.2% | 0.01% | +350.0% |
Q2 2020 | $303,000 | – | 18,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |